Using physics-based pose predictions and free energy perturbation calculations to predict binding poses and relative binding affinities for FXR ligands in the D3R Grand Challenge 2
暂无分享,去创建一个
Christina Athanasiou | Sofia Vasilakaki | Dimitris Dellis | Zoe Cournia | Z. Cournia | C. Athanasiou | Sofia Vasilakaki | D. Dellis
[1] Julien Michel,et al. Blinded predictions of binding modes and energies of HSP90-α ligands for the 2015 D3R grand challenge. , 2016, Bioorganic & medicinal chemistry.
[2] Robert Abel,et al. Motifs for molecular recognition exploiting hydrophobic enclosure in protein–ligand binding , 2007, Proceedings of the National Academy of Sciences.
[3] Shuai Liu,et al. D3R grand challenge 2015: Evaluation of protein–ligand pose and affinity predictions , 2016, Journal of Computer-Aided Molecular Design.
[4] Woody Sherman,et al. Large-Scale Systematic Analysis of 2D Fingerprint Methods and Parameters to Improve Virtual Screening Enrichments , 2010, J. Chem. Inf. Model..
[5] Woody Sherman,et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.
[6] Kenneth D. Jordan,et al. Comparison of Density Functional and MP2 Calculations on the Water Monomer and Dimer , 1994 .
[7] Peter A. Kollman,et al. FREE ENERGY CALCULATIONS : APPLICATIONS TO CHEMICAL AND BIOCHEMICAL PHENOMENA , 1993 .
[8] Peter A. Kollman,et al. Free energy calculations on protein stability: Thr-157 .fwdarw. Val-157 mutation of T4 lysozyme , 1989 .
[9] Hans Richter,et al. Identification of an N-oxide pyridine GW4064 analog as a potent FXR agonist. , 2009, Bioorganic & medicinal chemistry letters.
[10] Shuai Liu,et al. Lead optimization mapper: automating free energy calculations for lead optimization , 2013, Journal of Computer-Aided Molecular Design.
[11] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[12] B. Brooks,et al. An analysis of the accuracy of Langevin and molecular dynamics algorithms , 1988 .
[13] Z. Xiang,et al. On the role of the crystal environment in determining protein side-chain conformations. , 2002, Journal of molecular biology.
[14] Ruhong Zhou,et al. Single mutation induced H3N2 hemagglutinin antibody neutralization: a free energy perturbation study. , 2008, The journal of physical chemistry. B.
[15] Jennifer L. Knight,et al. Modeling Local Structural Rearrangements Using FEP/REST: Application to Relative Binding Affinity Predictions of CDK2 Inhibitors. , 2013, Journal of chemical theory and computation.
[16] R. Friesner,et al. Novel procedure for modeling ligand/receptor induced fit effects. , 2006, Journal of medicinal chemistry.
[17] Charles H. Bennett,et al. Efficient estimation of free energy differences from Monte Carlo data , 1976 .
[18] David E. Shaw,et al. PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results , 2006, J. Comput. Aided Mol. Des..
[19] Gerhard Hummer,et al. Free Energy of Ionic Hydration , 1996 .
[20] Z. Deng,et al. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions. , 2004, Journal of medicinal chemistry.
[21] Francisco Adasme-Carreño,et al. Binding-affinity predictions of HSP90 in the D3R Grand Challenge 2015 with docking, MM/GBSA, QM/MM, and free-energy simulations , 2016, Journal of Computer-Aided Molecular Design.
[22] Mika A. Kastenholz,et al. Computation of methodology-independent ionic solvation free energies from molecular simulations. I. The electrostatic potential in molecular liquids. , 2006, The Journal of chemical physics.
[23] E. Lionta,et al. Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances , 2014, Current topics in medicinal chemistry.
[24] Yong Li,et al. The antiparasitic drug ivermectin is a novel FXR ligand that regulates metabolism , 2013, Nature Communications.
[25] W. L. Jorgensen. Efficient Drug Lead Discovery and Optimization , 2009 .
[26] B. Berne,et al. Replica exchange with solute scaling: a more efficient version of replica exchange with solute tempering (REST2). , 2011, The journal of physical chemistry. B.
[27] Stefan Westin,et al. Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR). , 2009, Journal of medicinal chemistry.
[28] Woody Sherman,et al. ConfGen: A Conformational Search Method for Efficient Generation of Bioactive Conformers , 2010, J. Chem. Inf. Model..
[29] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.
[30] R. Friesner,et al. New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies. , 2006, Bioorganic & medicinal chemistry.
[31] B. Berne,et al. Replica exchange with solute tempering: a method for sampling biological systems in explicit water. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. W. Becker,et al. Identification of a potent synthetic FXR agonist with an unexpected mode of binding and activation , 2008, Proceedings of the National Academy of Sciences.
[33] Hege S. Beard,et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.
[34] R. Abagyan,et al. Flexible ligand docking to multiple receptor conformations: a practical alternative. , 2008, Current opinion in structural biology.
[35] Z. Cournia,et al. Free Energy Calculations Reveal the Origin of Binding Preference for Aminoadamantane Blockers of Influenza A/M2TM Pore. , 2013, Journal of chemical theory and computation.
[36] Roberto Pellicciari,et al. Structural basis for bile acid binding and activation of the nuclear receptor FXR. , 2003, Molecular cell.
[37] Lingle Wang,et al. On achieving high accuracy and reliability in the calculation of relative protein–ligand binding affinities , 2012, Proceedings of the National Academy of Sciences.
[38] B. Berne,et al. Role of the active-site solvent in the thermodynamics of factor Xa ligand binding. , 2008, Journal of the American Chemical Society.
[39] Woody Sherman,et al. Use of an Induced Fit Receptor Structure in Virtual Screening , 2006, Chemical biology & drug design.
[40] Atli Thorarensen,et al. Imidazotriazines: Spleen Tyrosine Kinase (Syk) Inhibitors Identified by Free‐Energy Perturbation (FEP) , 2016, ChemMedChem.
[41] David Calkins,et al. Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution , 2010, J. Comput. Aided Mol. Des..
[42] Heather A Carlson,et al. Exploring experimental sources of multiple protein conformations in structure-based drug design. , 2007, Journal of the American Chemical Society.
[43] Charles C. Persinger,et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.
[44] Franz Schuler,et al. Discovery of novel and orally active FXR agonists for the potential treatment of dyslipidemia & diabetes. , 2011, Bioorganic & medicinal chemistry letters.
[45] Peter A. Kollman,et al. Free energy perturbation simulations of the inhibition of thermolysin: prediction of the free energy of binding of a new inhibitor , 1989 .
[46] William L Jorgensen,et al. Perspective on Free-Energy Perturbation Calculations for Chemical Equilibria. , 2008, Journal of chemical theory and computation.
[47] Zoe Cournia,et al. Structural Characterization and Computer‐Aided Optimization of a Small‐Molecule Inhibitor of the Arp2/3 Complex, a Key Regulator of the Actin Cytoskeleton , 2012, ChemMedChem.
[48] B. Kuhn,et al. Optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) agonists to improve physicochemical and ADME properties. , 2011, Bioorganic & medicinal chemistry letters.
[49] W. L. Jorgensen,et al. Monte Carlo simulation of differences in free energies of hydration , 1985 .
[50] B. Honig,et al. A hierarchical approach to all‐atom protein loop prediction , 2004, Proteins.
[51] Peter A. Kollman,et al. Computer modeling of the interactions of complex molecules , 1990 .
[52] Shawn P. Williams,et al. FXR agonist activity of conformationally constrained analogs of GW 4064. , 2009, Bioorganic & medicinal chemistry letters.
[53] Matthew P. Repasky,et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.
[54] M. Bowman,et al. A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. , 2003, Molecular cell.
[55] Shawn P Williams,et al. Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064. , 2009, Bioorganic & medicinal chemistry letters.
[56] Mika A. Kastenholz,et al. Computation of methodology-independent ionic solvation free energies from molecular simulations. II. The hydration free energy of the sodium cation. , 2006, The Journal of chemical physics.
[57] Jeremy R. Greenwood,et al. Epik: a software program for pKa prediction and protonation state generation for drug-like molecules , 2007, J. Comput. Aided Mol. Des..
[58] G. B. Wisely,et al. Conformationally constrained farnesoid X receptor (FXR) agonists: alternative replacements of the stilbene. , 2011, Bioorganic & medicinal chemistry letters.
[59] James Andrew McCammon,et al. Ligand-receptor interactions , 1984, Comput. Chem..
[60] Peng Liu,et al. Structural Basis for Small Molecule NDB (N-Benzyl-N-(3-(tert-butyl)-4-hydroxyphenyl)-2,6-dichloro-4-(dimethylamino) Benzamide) as a Selective Antagonist of Farnesoid X Receptor α (FXRα) in Stabilizing the Homodimerization of the Receptor* , 2015, The Journal of Biological Chemistry.
[61] Jennifer L. Knight,et al. Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field. , 2015, Journal of the American Chemical Society.
[62] Jing Zhang,et al. Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences , 2013 .
[63] M. Evans,et al. Improvement of physiochemical properties of the tetrahydroazepinoindole series of farnesoid X receptor (FXR) agonists: beneficial modulation of lipids in primates. , 2010, Journal of medicinal chemistry.
[64] Woody Sherman,et al. Rapid Shape-Based Ligand Alignment and Virtual Screening Method Based on Atom/Feature-Pair Similarities and Volume Overlap Scoring , 2011, J. Chem. Inf. Model..
[65] Thomas Fox,et al. Accuracy Assessment and Automation of Free Energy Calculations for Drug Design , 2014, J. Chem. Inf. Model..
[66] Clara D. Christ. Binding affinity prediction from molecular simulations: A new standard method in structure-based drug design? , 2016 .
[67] William L. Jorgensen,et al. Free energy calculations: a breakthrough for modeling organic chemistry in solution , 1989 .
[68] I. Kuntz,et al. Molecular docking to ensembles of protein structures. , 1997, Journal of molecular biology.
[69] Edward D Harder,et al. How To Deal with Multiple Binding Poses in Alchemical Relative Protein–Ligand Binding Free Energy Calculations , 2015, Journal of chemical theory and computation.
[70] Herman van Vlijmen,et al. Computational chemistry at Janssen , 2017, Journal of Computer-Aided Molecular Design.
[71] Pratyush Tiwary,et al. Prediction of Protein-Ligand Binding Poses via a Combination of Induced Fit Docking and Metadynamics Simulations. , 2016, Journal of chemical theory and computation.
[72] Claudio Chuaqui,et al. Structural Interaction Fingerprints: A New Approach to Organizing, Mining, Analyzing, and Designing Protein–Small Molecule Complexes , 2006, Chemical biology & drug design.
[73] H. Berendsen,et al. Molecular dynamics with coupling to an external bath , 1984 .